Phencyclidine (PCP)-induced social withdrawal in rats serves as a validated model of the negative symptoms observed in schizophrenia. This study demonstrates that the behavioral deficit is not due to global endocannabinoid system dysfunction, but rather to impaired on-demand activation of cannabinoid CB1 receptors. While baseline endocannabinoid levels remain unchanged under resting conditions, acute social interaction triggers a significant reduction in anandamide (AEA) concentrations specifically in the amygdala and medial prefrontal cortex (mPFC) of PCP-treated animals. This deficit correlates with reduced time spent in social behaviors such as sniffing, climbing, and following. The failure to mobilize AEA during social engagement suggests a disruption in activity-dependent signaling pathways rather than a structural or enzymatic deficiency. Biochemical analysis revealed no alteration in CB1 receptor expression or FAAH protein levels, indicating intact receptor availability and catabolic capacity. However, pharmacological enhancement of AEA via URB597 restored social interaction in PCP-treated rats, confirming that elevated AEA can overcome the functional deficit.2-(Methylthio)benzothiazole Drug Derivative Notably, this beneficial effect was blocked by the CB1 antagonist AM251, proving its dependence on CB1 receptor stimulation.Triphenylmethanol Biochemical Assay Reagents In contrast, URB597 reduced social interaction in control animals, an effect mediated through a non-CB1, non-TRPV1 cannabinoid/vanilloid-sensitive receptor.PMID:35028900 This paradoxical outcome highlights the dual role of endocannabinoids: physiological activation supports social behavior, while excessive elevation disrupts it. Further investigation revealed that PKA phosphorylation—critical for AEA synthesis via NAPE-PLD—is significantly reduced in the mPFC of PCP-treated rats, suggesting upstream dysregulation of the cAMP-PKA pathway. This impairment may explain the deficient AEA release during social interaction. Additionally, the CCK2 receptor antagonist LY225910 reversed both PCP- and AM251-induced social withdrawal, implicating disinhibition of CCK-expressing GABAergic interneurons as a key mechanism. Together, these findings establish that PCP-induced social withdrawal stems from a specific deficit in endocannabinoid mobilization leading to inadequate CB1 receptor activation, particularly in circuits governing emotional and social processing. Restoring this balance offers a promising avenue for treating negative symptoms in schizophrenia without triggering adverse effects seen with broad cannabinoid agonism.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com